Quitting Matters Human Immunodeficiency Virus Hybrid Trial

NARecruitingINTERVENTIONAL
Enrollment

474

Participants

Timeline

Start Date

August 18, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
TobaccoTobacco AbstinenceSmoking CessationSmoking Cessation; Tobacco DependenceHuman Immunodeficiency Virus (HIV)Tobacco Dependence Caused by CigarettesCancer Prevention
Interventions
BEHAVIORAL

Learn to Quit-HIV (LTQ-H) App

LTQ-H consists of 319 screens divided into: (a) HIV-tailored smoking cessation ACT skills, (b) education about tobacco dependence and treatment (USCPG), and (c) NRT psychoeducation and adherence. Content is gradually presented across 28 modules (14 education and 14 skills) that can be completed in 14 days.

BEHAVIORAL

QuitStart

This DTx, QuitGuide was adapted from the National Cancer Institute Smokefree.gov Initiative's QuitGuide's 5 modules have the following intervention components: (a) psychoeducation about the impact of smoking on health, (b) setting up a quit date and a quit plan, (c) selecting reasons for quitting, (d) tracking triggers and smoking habits, and (e) tips for quitting.

Trial Locations (1)

27101

RECRUITING

Wake Forest University, Implementation Science, Winston-Salem

All Listed Sponsors
collaborator

University at Buffalo

OTHER

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT06883097 - Quitting Matters Human Immunodeficiency Virus Hybrid Trial | Biotech Hunter | Biotech Hunter